National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 1 of 1 Research Studies DisplayedTien YY, Link BK, Brooks JM
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile.
This study characterized treatment choices and compared the 3-year overall survival rates of 8262 Medicare beneficiaries diagnosed with diffuse large B-cell lymphoma in 2000 – 2006. It found that patients treated with anthracycline-containing regimens with rituximab have the highest survival rates when all available clinical features are accounted for.
AHRQ-funded; HS016094.
Citation: Tien YY, Link BK, Brooks JM .
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile.
Leuk Lymphoma 2015 Jan;56(1):65-71. doi: 10.3109/10428194.2014.903589..
Keywords: Comparative Effectiveness, Medicare, Outcomes, Cancer, Mortality